HOME >> BIOLOGY >> NEWS
New diagnostic tool brings effective treatment closer to patients

Hamburg, Germany: Significant progress towards identifying the genetic make-up of individual tumours, hence allowing treatment choices to be made based on personalised information was announced at the 4th European Breast Cancer Conference, today. Dr. Alane Koki, Chief Scientific Officer of Ipsogen, a French biotechnology company, told a news briefing that, subject to the successful conclusion of ongoing validation studies, the Breast Cancer ProfileChipTM (BCPC) should be available for use in pathology laboratories by Summer 2004.

One of the biggest obstacles to effective breast cancer treatment and management is the amount of genetic variability between patients. The BCPC uses microarray technology* to look at the individual molecular characteristics of each patient's tumour. "Understanding differences in gene expression can help both patients and clinicians to decide what treatment would be most effective and appropriate with a personalised approach", said Dr. Koki.

Looking at the 'genetic signature' of a tumour can provide crucial information to contribute to the choice of first-line treatment. It can also avoid over-treatment or prolonged treatment with ineffective drugs and the associated side effects. The use of microarrays will be able to predict relapse or metastatic disease in patients treated by the current standard of care, therefore sparing selected patients from chemotherapy or closer monitoring and/or dose intensification in patients at high risk. The information provided by this new tool should lead to better management of breast cancer, improve the quality of patient life, as well as reduce the costs of treatment to health services.

"To our knowledge, the BCPC will be the first microarray diagnostic tool available to local pathology laboratories, thus bringing the technology closer to the patient", said Dr. Koki. Although a few similar diagnostic methods are already available, to date they have involved sen
'"/>

Contact: Mary Rice
mary.rice@blueprintpartners.be
49-40-3569-3625
Federation of European Cancer Societies
17-Mar-2004


Page: 1 2

Related biology news :

1. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
2. New diagnostic technology helps justify earlier cataract surgery
3. Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery
4. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
5. Worlds leading mad cow diagnostic company, responds to USDAs additional BSE protection measures
6. Advances in prosthetic, orthopedic, and audiologic diagnostic tools
7. FDA clears for market new diagnostic test for lupus
8. New method of DNA testing promises to transform medical diagnostics
9. Leading lab expert to update medical community on diagnostic testing for thyroid function
10. New Arizona State center brings science to policy on issues of water resources and urban growth
11. From science fiction to reality: Nanomedicine brings fresh hope to the medical world

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... ... Harper was three years old when her owners took her to the veterinarian ... in the joints. She was referred to a veterinary specialist to perform “salvage ... Christopher Eich of Southern California Veterinary Specialty Hospital , examined Harper and recommended ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... Windows and mobile, announces the launch of version 13.1. The new version extends ... Management API, and supports Apple’s spring release functionality. Version 13.1 builds on FileWave’s ...
(Date:5/26/2019)... (PRWEB) , ... May 24, 2019 , ... Zolgensma (Novartis, ... as AVXS-101, was approved for clinical use in the United States by the Food ... virally-delivered gene therapy approved to treat inherited genetic disorders in the United States and ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
(Date:6/6/2019)... ... 05, 2019 , ... WCCT Global, Inc ., a full-service early phase ... they will be receiving 3 awards at the 2019 CRO Leadership Awards, to be ... the categories of overall Quality and Compatibility (Access to desired markets, cultural fit, timely ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object ... announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the ... ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as well ...
Breaking Biology Technology:
Cached News: